|This article or section may have been copied and pasted from virbac.com, possibly in violation of Wikipedia's copyright policy. Please remedy this by editing this article to remove any non-free copyrighted content and attributing free content correctly, or flagging the content for deletion. Please be sure that the source of the copyright violation is not itself a Wikipedia mirror. (October 2013)|
|Traded as||Euronext: VIRP|
|Industry||Animal Health Care|
|Founder||Veterinary physician Pierre-Richard Dick|
Number of locations
|More than 100 countries|
|Products||Antibiotics, vaccines, dermatology, antiparasitics, dental hygiene...|
|Revenue||773 M€ (2014)|
Number of employees
The company is the 8th largest veterinarian pharmaceutical group with a turnover of 736 million euros in 2013. The company is a limited company with Executive and Supervisory Board. It is listed on the Paris Stock Exchange since 1985 and member of the SBF 120. The founder's family is the majority shareholder of the company.
The company has 4,350 employees and is present in over 100 countries with 30 sales subsidiaries.Its production is located in 10 countries among which France, the US, Mexico, Brazil, Vietnam. It also has seven research and development centers located in the United States, Mexico, Chile, Uruguay, France, Vietnam and Australia Source. It generates nearly 87% of its revenues outside France.
Its product range is designed to cover the main pathologies in companion animals and livestock: internal and external parasiticides (collars and pipettes), antibiotics, vaccines, diagnostic tests, dog and cat nutrition, dermatology, dental hygiene, reproductive, aquaculture, anesthesia, geriatrics and electronic identification (pets, horses, exotic pets…).